Aleksandra Jawiarczyk-Przybyłowska

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Health Information

Postmenopausal Women

Catheter Ablation

Top Venues

Reviews in endocrine & metabolic disorders

Endokrynologia Polska

This page only lists publications with an associated author ORCID identifier.

Publications

Justyna Kuliczkowska-Płaksej, Aleksandra Zdrojowy-Wełna, Aleksandra Jawiarczyk-Przybyłowska, Łukasz Gojny, Marek Bolanowski
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism. Reviews in endocrine & metabolic disorders (2024)
Justyna Kuliczkowska-Płaksej, Aleksandra Zdrojowy-Wełna, Aleksandra Jawiarczyk-Przybyłowska, Łukasz Gojny, Marek Bolanowski
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism. Reviews in endocrine & metabolic disorders 25 (3) (2024)
Justyna Kuliczkowska-Płaksej, Aleksandra Zdrojowy-Wełna, Aleksandra Jawiarczyk-Przybyłowska, Łukasz Gojny, Marek Bolanowski
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism. Reviews in endocrine & metabolic disorders 25 (3) (2024)
Justyna Kuliczkowska-Płaksej, Aleksandra Zdrojowy-Wełna, Aleksandra Jawiarczyk-Przybyłowska, Łukasz Gojny, Marek Bolanowski
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism. Reviews in endocrine & metabolic disorders 25 (3) (2024)
Przemyslaw Witek, Anna Mehlich, Aleksandra Stasiewicz, Aleksandra Jawiarczyk-Przybyłowska, Marek Bolanowski
Osilodrostat - an emerging drug for the medical management of Cushing's disease. Endokrynologia Polska 73 (2) (2022)
Małgorzata Rolla, Łukasz Gojny, Aleksandra Jawiarczyk-Przybyłowska, Marek Bolanowski
Bone densitometry by radiofrequency echographic multi-spectrometry (REMS) in acromegaly patients. Endokrynologia Polska 71 (6) (2020)
Aleksandra Franczak, Katarzyna Kolačkov, Aleksandra Jawiarczyk-Przybyłowska, Marek Bolanowski
Association between FTO gene polymorphisms and HDL cholesterol concentration may cause higher risk of cardiovascular disease in patients with acromegaly. Pituitary 21 (1) (2018)